Resourceful Insights Related To The Sexually Transmitted Diseases Testing Market Included In The Research Report
Sexually transmitted diseases or venereal diseases (VDs) are one of the most critical health challenges facing the world today. Rising rates of incidence of fatal STDs, corresponding high-economic burden and consequent implementation of Provider-Initiated Counselling and Testing (PICT) and Client-Initiated Counselling and Testing (CICT) are factors that drive the growth of the diagnostic testing market for STDs. STDs are a grave issue globally, and are responsible for high morbidity in adults and cause infertility in both men and women. Complications such as ectopic pregnancy, cervical cancer in women and congenital mortality are observed in patients suffering from STDs. Generally, patients suffering from STDs are observed to be within 15 to 44 years, and ~500 million new cases of STDs are registered per year. Diagnostic procedures of STDs market include the technologies that are used to identify and analyze STD along with the laboratories where the tests are carried out.